A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
Becher OJ, Millard NE, Modak S, Kushner BH, Haque S, Spasojevic I, Trippett TM, Gilheeney SW, Khakoo Y, Lyden DC, De Braganca KC, Kolesar JM, Huse JT, Kramer K, Cheung NV, Dunkel IJ.
Becher OJ, et al. Among authors: huse jt.
PLoS One. 2017 Jun 5;12(6):e0178593. doi: 10.1371/journal.pone.0178593. eCollection 2017.
PLoS One. 2017.
PMID: 28582410
Free PMC article.
Clinical Trial.